Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TIM-1 is a type I transmembrane glycoprotein involved in T-cell activation, immune regulation, and tissue regeneration. It is overexpressed in various cancers and implicated in autoimmunity. It acts as a stimulatory molecule for T-cell activation, promoting proliferation and cytokine secretion by T cells and can mediate both co-stimulatory and co-inhibitory signals depending on context.
Targeted silencing inhibits cancer cell growth/progression.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell immunoglobulin and mucin domain-containing protein 1 (TIM-1).